BridgeMD
New treatment option for Postpartum Depression (PPD)
Official title EMA and mHealth in Preventing Postpartum Depression
ClinicalTrials.gov ID: NCT06777563
What this study is testing
- What it's testing
- This proposed study aims to develop and examine the feasibility, acceptability, and preliminary effectiveness of a proactive intervention model that combines brief psychological counselling, Ecological Momentary Assessment (EMA), mHealth-based psychological support, and CBT-guided telephone counselling to prevent postpartum depression (PPD).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Pregnant women who are in their 20 to 28 weeks of gestation,
- Receiving regular antenatal care service in Hong Kong,
- Had a total score ≥7 in EPDS-10 (suggesting potential distress symptoms),
- Able to read and understand Chinese and use an instant messaging app weekly
You likely can't join if
- 1) Pregnant women who are undergoing psychiatric/psychological treatment.
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Pokfulam, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Pokfulam, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.